Phase separation in immune regulation and immune-related diseases

N Huang, H Dong, B Shao - Journal of Molecular Medicine, 2022 - Springer
Phase separation is an emerging paradigm for understanding the biochemical interactions
between proteins, DNA, and RNA. Research over the past decade has provided mounting …

Molecular characterization of an intronic RNASEH2B variant in a patient with Aicardi-Goutières syndrome

ML Leung, W Woodhull, C Uggenti, S Schord… - European journal of …, 2023 - Elsevier
Aicardi-Goutières syndrome (AGS) is a progressive multisystem disorder including
encephalopathy with significant impacts on intellectual and physical abilities. An early …

mRNA-based vaccines against SARS-CoV-2 do not stimulate interferon stimulatory gene expression in individuals affected by Aicardi Goutières Syndrome

A Takanohashi, MG Alameh, S Woidill, J Hacker… - bioRxiv, 2022 - biorxiv.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses threats to
individuals with rare disease, in part because so little is known about the impact of COVID …

[HTML][HTML] Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c. 2471G> A …

S Masneri, G Lanzi, RM Ferraro, C Barisani… - Stem Cell Research, 2019 - Elsevier
Aicardi-Goutières syndrome (AGS) is an early-onset monogenic encephalopathy
characterized by intracranial calcification, leukodystrophy and cerebrospinal fluid …

[HTML][HTML] ADAR1相关神经系统疾病的遗传学机制与临床研究进展

李双, 王一, 王艺 - 2022 - jms.fudan.edu.cn
ADAR1 是引起神经系统表型Aicardi-Goutières 综合征(AGS) 的致病基因之一,
以常染色体隐性遗传为主. 临床以进行性肌张力障碍, 颅内白质钙化和血液及脑脊液中干扰素升 …

Aicardi-Goutières Syndrome Type 1: A Novel Missense Variant and Review of the Mutational Spectrum

B Tasharrofi, P Karimzadeh… - Iranian Journal of …, 2024 - journals.sbmu.ac.ir
Objectives Mutations in the TREX1 gene cause Aicardi-Goutières syndrome (AGS) 1,
associated with a spectrum of autoimmune and neurodegenerative manifestations. AGS 1 …

Preimplantation genetic testing for Aicardi–Goutières syndrome induced by novel compound heterozygous mutations of TREX1: an unaffected live birth

H Xu, J Pu, S Lin, R Hu, J Yao, X Li - Molecular Cytogenetics, 2023 - Springer
Abstract Background Aicardi–Goutières syndrome (AGS) is a rare, autosomal recessive,
hereditary neurodegenerative disorder. It is characterized mainly by early onset progressive …

Juvenile Dermatomyositis and Infantile Cerebral Palsy: Aicardi-Gouteres Syndrome, Type 5, with a Novel Mutation in SAMHD1—A Case Report

LS Sorokina, RK Raupov, MM Kostik - Biomedicines, 2023 - mdpi.com
Introduction: Aicardi-Gouteres syndrome (AGS) is a monogenic interferonopathy
characterized by early onset, dysregulation of skin (chilblain lesions), brain, and immune …

MEF2A suppresses replicative stress responses that trigger DDX41-dependent IFN production

JR Smith, JW Dowling, A Karp, J Schwerk, R Savan… - bioRxiv, 2022 - biorxiv.org
Interferons (IFN) are induced by sensing of self-and non-self DNA or genomic lesions by
pathogen recognition receptors (PRR) that activate STING. These pathways must be kept in …

Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent

SSC Abraham, S Yoganathan, B Koshy… - European Journal of …, 2021 - Elsevier
Abstract Aicardi-Goutieres Syndrome (AGS) is a heterogeneous genetic syndrome,
manifesting early as encephalopathy and is associated with abnormal neurologic findings …